Urology
Volume 76, Issue 2 , Pages 511.e5-511.e9 , August 2010

Insulin-like Growth Factor-1 Gene Delivery May Enhance the Proliferation of Human Corpus Cavernosal Smooth Muscle Cells

  • Minkyung Kim

      Affiliations

    • Department of Urology, Chonnam National University Medical School, Sexual Medicine Research Center, Chonnam National University, Gwangju, Republic of Korea
    • Department of Sexual Medicine Research Center, Chonnam National University Medical School, Sexual Medicine Research Center, Chonnam National University, Gwangju, Republic of Korea
    • ,
  • Eu Chang Hwang

      Affiliations

    • Department of Urology, Chonnam National University Medical School, Sexual Medicine Research Center, Chonnam National University, Gwangju, Republic of Korea
    • ,
  • In-Kyu Park

      Affiliations

    • Department of Biomedical Science, Chonnam National University Medical School, Sexual Medicine Research Center, Chonnam National University, Gwangju, Republic of Korea
    • ,
  • Kwangsung Park

      Affiliations

    • Department of Urology, Chonnam National University Medical School, Sexual Medicine Research Center, Chonnam National University, Gwangju, Republic of Korea
    • Department of Sexual Medicine Research Center, Chonnam National University Medical School, Sexual Medicine Research Center, Chonnam National University, Gwangju, Republic of Korea
    • Corresponding Author InformationReprint requests: Kwangsung Park, M.D., Ph.D., Department of Urology, Chonnam National University, Medical School, Sexual Medicine Research Center, Chonnam National University, 8 Hak-dong, Dong-Gu, Gwangju 501–757, Republic of Korea

Received 17 August 2009 ,Accepted 8 December 2009.

References 

  1. Christ GJ. The penis as a vascular organ (The importance of corporal smooth muscle tone in the control of erection). Urol Clin North Am. 1995;22:727–745
  2. Siroky MB, Azadzoi KM. Vasculogenic erectile dysfunction: newer therapeutic strategies. J Urol. 2003;170:S24–S29discussion S29-S30
  3. Andersson KE. Erectile physiological and pathophysiological pathways involved in erectile dysfunction. J Urol. 2003;170:S6–S13discussion S13-S14
  4. Wespes E, Sattar AA, Golzarian J, et al. Corporeal veno-occlusive dysfunction: predominantly intracavernous muscular pathology. J Urol. 1997;157:1678–1680
  5. Simopoulos DN, Gibbons SJ, Malysz J, et al. Corporeal structural and vascular micro architecture with X-ray microcomputerized tomography in normal and diabetic rabbits: histopathological correlation. J Urol. 2001;165:1776–1782
  6. Liu X, Lin CS, Graziottin T, et al. Vascular endothelial growth factor promotes proliferation and migration of cavernous smooth muscle cells. J Urol. 2001;166:354–360
  7. Park K, Ahn KY, Kim MK, et al. Intracavernosal injection of vascular endothelial growth factor improves erectile function in aged rats. Eur Urol. 2004;46:403–407
  8. Liu X, Lin CS, Spencer EM, et al. Insulin-like growth factor-I promotes proliferation and migration of cavernous smooth muscle cells. Biochem Biophys Res Commun. 2001;280:1307–1315
  9. Park K, Ahn KY, Kim MK, et al. Effect of insulin like growth factor-1 on erectile function and in aging rat. Aging Male. 2004;7:74
  10. Federici T, Boulis NM. Gene-based treatment of motor neuron diseases. Muscle Nerve. 2006;33:302–323
  11. Park IK, Lasiene J, Chou SH, et al. Neuron-specific delivery of nucleic acids mediated by Tet1-modified poly(ethylenimine). J Gene Med. 2007;9:691–702
  12. Kendirci M, Gur S, Sikka SC. Gene therapy for erectile dysfunction. Front Biosci. 2005;10:2758–2769
  13. Bivalacqua TJ, Strong TD. The use of gene transfer technology to study the pathophysiology of erectile dysfunction. J Sex Med. 2008;5:268–275
  14. Cohick WS, Clemmons DR. The insulin-like growth factors. Annu Rev Physiol. 1993;55:131–153
  15. Khan AS, Sane DC, Wannenburg T, et al. Growth hormone, insulin-like growth factor-1 and the aging cardiovascular system. Cardiovasc Res. 2002;54:25–35
  16. Dunn SE. Insulin-like growth factor I stimulates angiogenesis and the production of vascular endothelial growth factor. Growth Horm IGF Res. 2000;10(suppl A):S41–S42
  17. Rogers RS, Graziottin TM, Lin CS, et al. Intracavernosal vascular endothelial growth factor (VEGF) injection and adeno-associated virus-mediated VEGF gene therapy prevent and reverse venogenic erectile dysfunction in rats. Int J Impot Res. 2003;15:26–37
  18. Gholami SS, Rogers R, Chang J, et al. The effect of vascular endothelial growth factor and adeno-associated virus mediated brain derived neurotrophic factor on neurogenic and vasculogenic erectile dysfunction induced by hyperlipidemia. J Urol. 2003;169:1577–1581
  19. Pu XY, Hu LQ, Wang HP, et al. Improvement in erectile dysfunction after insulin-like growth factor-1 gene therapy in diabetic rats. Asian J Androl. 2007;9:83–91
  20. Jung GW, Kwak JY, Yoon S, et al. IGF-1 and TGF-beta2 have a key role on regeneration of nitric oxide synthase (NOS)-containing nerves after cavernous neurotomy in rats. Int J Impot Res. 1999;11:247–259

PII: S0090-4295(09)03071-4

doi: 10.1016/j.urology.2009.12.011

Urology
Volume 76, Issue 2 , Pages 511.e5-511.e9 , August 2010

Article Tools

* Image Usage & Resolution